رجوع
نطاق اليوم
KWD 2.58
KWD 3.56
نطاق 52 أسبوعًا
KWD 0.83
KWD 4.74
حجم التداول
1,000
متوسط 50 يوم / 200 يوم
KWD 2.91
/
KWD 3.49
الإغلاق السابق
KWD 2.58
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 2.9 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | 14.2 | 3.7 |
| Net Margin % | 23.0 | 3.9 |
| Rev Growth 5Y % | 13.0 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 1.395
KWD 1.094 – KWD 1.860
|
12 B | 1 |
| FY2026 |
KWD 1.298
KWD 1.018 – KWD 1.730
|
11 B | 1 |
النقاط الرئيسية
Revenue grew 12.99% annually over 5 years — strong growth
Earnings grew 34.93% over the past year
ROE of 14.19% — decent returns on equity
Net margin of 22.95% shows strong profitability
Debt/Equity of 0.23 — conservative balance sheet
Generating 2.24B in free cash flow
النمو
Revenue Growth (5Y)
12.99%
Revenue (1Y)16.53%
Earnings (1Y)34.93%
FCF Growth (3Y)36.19%
الجودة
Return on Equity
14.19%
ROIC10.79%
Net Margin22.95%
Op. Margin29.99%
الأمان
Debt / Equity
0.23
Current Ratio1.71
Interest Coverage14.31
التقييم
P/E Ratio
2.91
P/B Ratio0.39
EV/EBITDA2.79
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.53% | Revenue Growth (3Y) | 15.23% |
| Earnings Growth (1Y) | 34.93% | Earnings Growth (3Y) | 4.46% |
| Revenue Growth (5Y) | 12.99% | Earnings Growth (5Y) | 25.76% |
| Profitability | |||
| Revenue (TTM) | 9.11B | Net Income (TTM) | 2.09B |
| ROE | 14.19% | ROA | 8.63% |
| Gross Margin | 85.95% | Operating Margin | 29.99% |
| Net Margin | 22.95% | Free Cash Flow (TTM) | 2.24B |
| ROIC | 10.79% | FCF Growth (3Y) | 36.19% |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 1.71 |
| Interest Coverage | 14.31 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 2.91 | P/B Ratio | 0.39 |
| P/S Ratio | 0.67 | PEG Ratio | 0.19 |
| EV/EBITDA | 2.79 | Dividend Yield | 0.04% |
| Market Cap | 6.09B | Enterprise Value | 7.62B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 9.11B | 7.82B | 6.86B | 6.38B | 5.59B |
| Net Income | 2.09B | 1.55B | 1.92B | 1.65B | 835.79M |
| EPS (Diluted) | 0.85 | 0.62 | 0.74 | 0.62 | 0.33 |
| Gross Profit | 7.83B | 6.64B | 5.67B | 5.28B | 4.52B |
| Operating Income | 2.73B | 2.46B | 2.07B | 1.83B | 1.46B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 24.21B | 23.63B | 21.99B | 19.21B | 17.68B |
| Total Liabilities | 6.18B | 7.11B | 6.59B | 4.55B | 4.58B |
| Shareholders' Equity | 15.44B | 14.03B | 12.96B | 12.23B | 10.69B |
| Total Debt | 3.55B | 4.84B | 4.52B | 2.63B | 2.91B |
| Cash & Equivalents | 2.02B | 2.69B | 2.15B | 2.80B | 3.09B |
| Current Assets | 9.35B | 9.19B | 9.76B | 7.79B | 6.68B |
| Current Liabilities | 5.46B | 3.73B | 1.79B | 1.42B | 1.45B |
درجات الاستراتيجيات
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026